A Phase II Study of Neoadjuvant Sacituzumab Govitecan and Pembrolizumab Therapy for Immunochemotherapy-resistant Early-stage Triple-negative Breast Cancer (TNBC)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Gilead Sciences
Related studies linked through entity extraction aliases.
GPC2 CAR T Cells for Relapsed or Refractory Neuroblastoma and Metastatic Retinoblastoma
- Status
- RECRUITING
- Phase
- PHASE1
Pilot Mobile Medical Unit Study for I'm Fully Empowered4Her
- Status
- COMPLETED
- Phase
- NA
Study of Novel Treatment Combinations in Patients With Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
- Status
- RECRUITING
- Phase
- PHASE3
Study of Edecesertib in Participants With Cutaneous Lupus Erythematosus (CLE)
- Status
- TERMINATED
- Phase
- PHASE2
US Expanded Access Program for Magrolimab in Patients With Relapsed or Refractory Acute Myeloid Leukemia
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Study of Pembrolizumab (MK-3475) Monotherapy Versus Sacituzumab Govitecan in Combination With Pembrolizumab for Participants With Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-3475-D46)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Study of Obeldesivir in Participants With COVID-19 Who Have a High Risk of Developing Serious or Severe Illness
- Status
- TERMINATED
- Phase
- PHASE3
Study of Novel Antiretrovirals in Participants With HIV-1
- Status
- COMPLETED
- Phase
- PHASE1
Sacituzumab Govitecan Before Radical Cystectomy for the Treatment of Non-Urothelial Muscle Invasive Bladder Cancer
- Status
- TERMINATED
- Phase
- PHASE2
A Clinical Trial of a New Combination Treatment, Domvanalimab and Zimberelimab, Plus Chemotherapy, for People With an Upper Gastrointestinal Tract Cancer That Cannot be Removed With Surgery That Has Spread to Other Parts of the Body
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Safety and Efficacy Analysis of an Antibody Associated With a Chemotherapy for Patients With a Triple Negative Metastatic Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE3
Telehealth as a Modality to Increase the Uptake of PrEP Services in Black and Latino: "e-PrEP"
- Status
- COMPLETED
- Phase
- PHASE4
Advanced HIV: Outcomes for Rapid ART
- Status
- UNKNOWN
- Phase
- N/A
TelePrEP for At-risk Youth in Colorado
- Status
- RECRUITING
- Phase
- NA
Preventive stRategy for IMMU132-relatED AEs in TNBC or Luminal Breast Cancer- PRIMED
- Status
- COMPLETED
- Phase
- PHASE2
Elimination of Hepatitis C Virus Among Users of Substances
- Status
- UNKNOWN
- Phase
- N/A
Study to Compare Bictegravir/Lenacapavir Versus Current Therapy in People With HIV-1 Who Are Successfully Treated With a Complicated Regimen
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2/PHASE3
Zimberelimab and Domvanalimab in Combination With Chemotherapy Versus Pembrolizumab With Chemotherapy in Patients With Untreated Metastatic Non-Small Cell Lung Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3